TalkMed Group (SGX:5G3) Debt-to-Revenue : 0.10 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is TalkMed Group Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

TalkMed Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was S$4.73 Mil. TalkMed Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was S$4.45 Mil. TalkMed Group's annualized Revenue for the quarter that ended in Dec. 2023 was S$91.99 Mil. TalkMed Group's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.10.

TalkMed Group Debt-to-Revenue Historical Data

The historical data trend for TalkMed Group's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TalkMed Group Debt-to-Revenue Chart

TalkMed Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

Get a 7-Day Free Trial

0.12

0.16

0.15

0.09

0.11

TalkMed Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial															0.14	0.13	0.08	0.10	0.10

Competitive Comparison of TalkMed Group's Debt-to-Revenue

For the Medical Care Facilities subindustry, TalkMed Group's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TalkMed Group's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TalkMed Group's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where TalkMed Group's Debt-to-Revenue falls into.

TalkMed Group Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

TalkMed Group's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(4.727	+	4.45)	/	83.792
	=	0.11

TalkMed Group's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(4.727	+	4.45)	/	91.994
	=	0.10

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.

TalkMed Group Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of TalkMed Group's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

TalkMed Group (SGX:5G3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TalkMed Group Ltd (SGX:5G3) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Mount Elizabeth, Mount Elizabeth Hospital Level 2, Singapore, SGP, 228510

Website

https://www.talkmed.com.sg

TalkMed Group Ltd operates as an investment holding company. It is a provider of medical oncology, stem cell transplants and palliative care services, serving patients in Singapore and the region. Outside Singapore, the Group operates in Vietnam, Hong Kong and the People's Republic of China. The activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into three reportable operating segments, Oncology Services, Stem Cells Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, Hong Kong and Vietnam of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.

TalkMed Group (SGX:5G3) Headlines

No Headlines